Glucose levels and insulin secretion during a 75 g glucose challenge test in normal pregnancy

Agardh, Carl‐David; Åberg, Anders; Nordén, Nils E.

doi:10.1046/j.1365-2796.1996.52872000.x

Cited by 38 publications

(23 citation statements)

References 17 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…In brief, we found no overall significant difference between oral treatment and insulin for the following outcomes (with the numbers in brackets denoting the total number of RCTs and observational studies respectively): rates of preeclampsia (3,6), caesarean delivery (6,8), maternal 2-hour PG (1, 1), maternal mean BG (1,1), maternal HbA 1c (2, 0), induction of labour (3, 1), macrosomia (2,8), LGA (3, 6), perinatal mortality (4, 6), birth trauma (3, 5), hyperbilirubnaemia (3,4), need for phototherapy (2,6), SGA (2, 5), NICU admission (3,8), congenital malformations (3, 6), respiratory distress (3, 5) and 1-minute Apgar score (1,4).…”

Section: Other Outcomesmentioning

confidence: 79%

See 1 more Smart Citation

Screening for hyperglycaemia in pregnancy: a rapid update for the National Screening Committee

Waugh

Royle²,

Clar³

et al. 2010

Health Technol Assess

View full text Add to dashboard Cite

How to obtain copies of this and other HTA programme reports An electronic version of this title, in Adobe Acrobat format, is available for downloading free of charge for personal use from the HTA website (www.hta.ac.uk). A fully searchable DVD is also available (see below). Printed copies of HTA journal series issues cost £20 each (post and packing free in the UK) to both public and private sector purchasers from our despatch agents. Non-UK purchasers will have to pay a small fee for post and packing. For European countries the cost is £2 per issue and for the rest of the world £3 per issue. How to order:-fax (with credit card details)-post (with credit card details or cheque)-phone during office hours (credit card only). Additionally the HTA website allows you to either print out your order or download a blank order form. Tel: 0845 812 4000-ask for 'HTA Payment Services' (out-of-hours answer-phone service) Fax: 0845 812 4001-put 'HTA Order' on the fax header Payment methods Paying by cheque If you pay by cheque, the cheque must be in pounds sterling, made payable to University of Southampton and drawn on a bank with a UK address. Paying by credit card You can order using your credit card by phone, fax or post. Subscriptions NHS libraries can subscribe free of charge. Public libraries can subscribe at a reduced cost of £100 for each volume (normally comprising 40-50 titles). The commercial subscription rate is £400 per volume (addresses within the UK) and £600 per volume (addresses outside the UK). Please see our website for details. Subscriptions can be purchased only for the current or forthcoming volume. How do I get a copy of HTA on DVD? Please use the form on the HTA website (www.hta.ac.uk/htacd/index.shtml). HTA on DVD is currently free of charge worldwide. The website also provides information about the HTA programme and lists the membership of the various committees. Research (NIHR), was set up in 1993. It produces high-quality research information on the effectiveness, costs and broader impact of health technologies for those who use, manage and provide care in the NHS. 'Health technologies' are broadly defined as all interventions used to promote health, prevent and treat disease, and improve rehabilitation and long-term care. The research findings from the HTA programme directly influence decision-making bodies such as the National Institute for Health and Clinical Excellence (NICE) and the National Screening Committee (NSC). HTA findings also help to improve the quality of clinical practice in the NHS indirectly in that they form a key component of the 'National Knowledge Service'. The HTA programme is needs led in that it fills gaps in the evidence needed by the NHS. There are three routes to the start of projects. First is the commissioned route. Suggestions for research are actively sought from people working in the NHS, from the public and consumer groups and from professional bodies such as royal colleges and NHS trusts. These suggestions are carefully prioritised by panels of independent exper...

show abstract

Section: Other Outcomesmentioning

confidence: 79%

“…This failed to take into account the physiological rise in post-prandial glucose (PPG) levels in pregnancy. In a Swedish study, 6 the mean 2-hour plasma glucose (PG) level was 8.0 mmol/l; if the WHO criteria were applied, 18% would have had GDM.…”

Section: The Previous Health Technology Assessment Reviewmentioning

confidence: 99%

Screening for hyperglycaemia in pregnancy: a rapid update for the National Screening Committee

Waugh

Royle²,

Clar³

et al. 2010

Health Technol Assess

View full text Add to dashboard Cite

show abstract

“…It has been suggested that gestational hormones are involved in metabolic changes of pregnancy, as hormones of the placental lactogen, growth hormone, and prolactin family enhances insulin production and release, as well as cell proliferation in islets of Langerhans. Simultaneously with the changes in the endocrine and the pancreas, the sensitivity of the maternal tissues for insulin decreases during pregnancy, thereby increasing the demand for insulin [19,20].…”

Section: Discussionmentioning

confidence: 99%

Waist circumference is the key risk factor for diabetes in Korean women with history of gestational diabetes

Cho

Jang

Park³

et al. 2006

Diabetes Research and Clinical Practice

View full text Add to dashboard Cite

“…Early screening during pregnancy is based on one FPG measurement with the same threshold as after 24 weeks of gestation, as FPG varies little during pregnancy [26,27]. Indeed, FPG levels decrease early in pregnancy with only a slight further decrease later on [28].…”

Section: Issues and Proposals For Screening During Early Pregnancymentioning

confidence: 99%

“…The WHO Guideline Development Group also adopted the IADPSG criteria for any time during pregnancy. However, this remains an issue as post-OGTT glucose values have been reported to be lower at week 17 than at week 32 of gestation in women without GDM tested twice during pregnancy [26]. Therefore, the performance of the use of the glucose OGTT threshold combination to diagnose moderate hyperglycaemia during pregnancy is still unknown, and it appears difficult to consider the OGTT an efficient diagnostic test during early pregnancy.…”

Section: Issues and Proposals For Screening During Early Pregnancymentioning

confidence: 99%

Screening for dysglycaemia during pregnancy: Proposals conciliating International Association of Diabetes and Pregnancy Study Group (IADPSG) and US National Institutes of Health (NIH) panels

Cosson

Valensi

Carbillon

2015

Diabetes & Metabolism

View full text Add to dashboard Cite

Glucose levels and insulin secretion during a 75 g glucose challenge test in normal pregnancy

Cited by 38 publications

References 17 publications

Screening for hyperglycaemia in pregnancy: a rapid update for the National Screening Committee

Screening for hyperglycaemia in pregnancy: a rapid update for the National Screening Committee

Waist circumference is the key risk factor for diabetes in Korean women with history of gestational diabetes

Screening for dysglycaemia during pregnancy: Proposals conciliating International Association of Diabetes and Pregnancy Study Group (IADPSG) and US National Institutes of Health (NIH) panels

Contact Info

Product

Resources

About